DelMar Pharmaceuticals

• 

  DelMar Pharmaceuticals Announces Approval for Listing on NASDAQ

  3:19 PM | July 11, 2016

  DMPI to Begin Trading on NASDAQ Capital Market on July 12, 2016 VANCOUVER, British Columbia and MENLO PARK, Calif., July 11, 2016, DMPI, /PRNewswire/ — DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) (“DelMar” and the “Company”), a company focused on developing and commercializing proven cancer therapies in new orphan drug indications, announced today that it has received approval from the Nasdaq Stock Market LLC (“NASDAQ”) for the listing of its common stock on the NASDAQ Capital Market. DelMar’s common stock will begin

  Read more
• Positive Test Results From SGS Substantiate Britannia’s $100 Million Distribution Deal

  3:05 PM | June 18, 2014

  NEW YORK, NY–(Marketwired – Jun 18, 2014) – Britannia Mining, Inc. (PINKSHEETS: BMIN) (or the Company), a UK based mining development Company, announced today that SGS, the world’s leading inspection, verification, testing and certification company has tested samples of the Malaysian ready mined iron ore stockpiles — secured by Britannia — yielding results that substantiate the Company’s strategy to supply steelmakers. “As there are few ores that can be added directly into a blast furnace for steel making,” said Kenneth Roberts, CEO of

  Read more